Dr. Khawaja K. Hamid M.D.

Recommended Articles

• Is Ovarian Cancer Hereditary?

  All women in the world are at some risk of getting ovarian cancer. Some of them are at greater risk because there are many risk factors, including the family history factor, which can cause the disease to be passed from one female family member to another. If a mother is diagnosed with ovarian...

• Ovarian Cancer: Why a Second Opinion Is Essential

  You know how crucial early detection is when it comes to ovarian cancer. Eighty-five percent of the time when women are diagnosed they are at a late stage and have a decreased likelihood of survival.The fact that this diagnosis needs to come quickly is the first area of concern. There isn’t much...

• What Impact Does Hospital Volume Have on Ovarian Cancer Survival?

  Ovarian cancer is one of the most difficult cancers to treat. Though overall survival is generally over 90% if caught early, only about 15% of ovarian cancers are diagnosed at early stages. This means that many women are diagnosed with ovarian cancer at more advanced stages with high mortality.With...

• Breast Cancer: Signs, Symptoms, and Diagnosis

  Breast cancer is the second most common cause of cancer related deaths in women. If breast cancer is diagnosed early, you are more likely to have a better outcome. So, it is always best to know the common signs and symptoms of breast cancer. Most women suffering with breast cancer may not show any...

• High-Fat Diet Linked to Increased Risk of Breast Cancer Across Generations

  New findings may improve the understanding of how breast cancer develops, and help people learn how to work towards prevention.When a person is told that they have breast cancer, it is common for them and their loved ones to want to know what caused the disease. Unfortunately, nobody knows the exact...

• NHS Strikes Deal for Cutting Edge Cancer Treatment for Adults with Lymphoma

  The National Health Service (NHS) is the publicly-funded national healthcare system for England. Together with the biopharmaceutical company, Gilead Sciences, the two organizations have reached an agreement to provide CAR T-cell therapy to patients with a type of cancer that has, sadly, left them...